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We report a case ofnon-Hodgkin’slymphoma found at the orifice ofrightB2 accompanied by
peripheral lung cancer in a 66-year-old asymptomatic man. Chest X-ray films showed a mass
shadow in the left lower lung field. Transbronchial lung biopsy of left $9 demonstrated
squamous cell carcinoma. Simultaneously wall thickening at the orifice of the right B2 was
found coincidentally. The biopsy specimen from that site showed non-Hodgkin’s lymphoma
(diffuse B-cell type). After left lower lobectomy, systemic chemotherapy was performed. It is
rare for malignant lymphoma to be recognized bronchofiberscopically.
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1. INTRODUCTION
Endobronchial involvement of malignant lym-
phoma is extremely rare [1], and primary lympho-
mas in pulmonary parenchymal tissue account only
for 0.45% of all pulmonary malignancies [2]. Thus,
we report a case of malignant lymphoma that was
entirely visible bronchoscopically and was accom-
panied by peripheral lung cancer.
2. CASE REPORT
A 66-year-old man who suffered from laryngeal
cancer underwent microsurgery in October, 1997
followed by radiotherapy. The histologic type was
moderately differentiated squamous cell carcinoma
and the clinical stage was TlaNOM0. In August,
1999, he was referred to our department for detailed
examinations for an abnormal shadow on chest
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X-ray film (Fig. 1). His past history was non-
contributory apart from his laryngeal cancer. He
had never smoked and was asymptomatic. Physical
examinations, including lymphonode palpation,
showed no abnormalities. A complete blood count
revealed; hemoglobin, 14.0 g/dl; leukocyte count,
9.2 103/mm
3 with 70.6% neutrophils, 1.8% eosin-
ophils, 0.2% basophils, 21.3 lymphocytes and 6.1%
monocytes; platelet count 206 103/mm3. Serum
chemistry showed no abnormality, including tumor
markers. CT scan revealed an irregular mass in
left $9 (Fig. 2). Lymphadenopathy was seen in the
hilar and subcarinal regions. To obtain a definitive
diagnosis, transbronchial lung biopsy was per-
formed and the biopsy specimen showed a squa-
mous cell carcinoma of the peripheral lung.
Simultaneously a 2 3mm area of thickened bron-
chialwallwas found at the orifice ofrightB2 (Fig. 3).
Immunohistochemical staining as well as hematox-
ylin and eosin staining for the biopsy specimen
from this small lesion were performed (Fig. 4).
Findings were negative for LCA, cytokeratin, CG-
A, anti-CD43 and CD45RO. Since findings were
positive for anti-LN-3, anti-CD20 and anti-CD79,
a definitive diagnosis of diffuse B-cell type non-
Hodgkin’s lymphomawas made.A systemic survey,
including abdominal and brain CT, bone and Ga-
scintigraphy, showed no metastatic lesions. Sys-
temic chemotherapy, using cisplatin and etoposide
was performed and was effective not only for
carcinoma but also for lymphoma (Fig. 5(a)). After
that, a left lower lobectomy with lymph node
dissection via a left thoracotomy was performed.
No pleural effusion, adhesion or dissemination were
seen. Gross pathologic examination of the resected
tumor indicated that it measured 2.5 2.4 2.5 cm
FIGURE Chest X-ray film on admission showing a mass
shadow in the left lower lung field (arrow).
FIGURE 2 Chest CT scan showing a tumorous lesion in
left $9.
FIGURE 3 Bronchofiberscopy found a wall thickening of
the orifice of right B2 unexpectedly.EARLY STAGE PULMONARY LYMPHOMA 181
FIGURE 4 Histological stain of the endobronchial lesion
shows proliferation of slightly atypical lymphocytes.
in size. The pathological report described a moder-
ately differentiated primary squamous cell carci-
noma of left $9. Lymph node metastases were
proven in subcarinal, hilar and interlobular nodes
pathologically. Adjuvant chemotherapy, consisting
of cisplatin, vinorelbine and prednisolone, was
added. Bronchoscopy proved complete remission
of the lymphoma cytologically and pathologically
(Fig. 5(b)).
3. DISCUSSION
Most cases of primary pulmonary lymphoma are
non-Hodgkin’s type. They have a solitary nodule,
mass or infiltration on chest X-ray or scanning and
seldom involve [3] endobronchial tissue, particu-
larly the region visualized by bronchofiberscopy. In
this case, bronchoscopy for the examination of the
peripheral cancer unexpectedly discovered a tiny
lesion at the orifice of B2 that was negative on the
chest radiograph. Immunohistochemical stainings
proved that this tumor consisted of B-cell features.
A hematoxylin and eosin staining showed prolifera-
tion of somewhat atypical and large lymphocytes
with notched nuclei. These findings are common to
diffuse B-cell type non-Hodgkin’s lymphomas.
Lymphomas that appear to arise from closely
related bronchus-associated lymphoid tissue are
known as BALT. BALTs have a tendency to remain
localized in the lung for long periods [4]. This case
FIGURE 5 Bronchoscopical changes of the lymphoma
along with treatments. (a) Pre-operative chemotherapy for the
carcinoma was also effective for the lymphoma: a reddening
of the mucosa could be observed but the tumor mass had
disappeared. (b) No malignancy was proven cytologically or
pathologically after two courses of chemotherapy, with red-
ness in the mucosa.
might have been a BALT but we could not prove it,
as the biopsy specimen was insufficient to assess
centrocyte-like cells or lymphoepithelial lesions [5].
The clinical stage of this case was IE because the
diagnostic images showed no abnormality outside
the thoracic cavity. Although there is no definition
for early stage lymphoma in a strict sense, this case
might be considered to be early stage lymphoma
because of its bronchoscopical findings.182 H. SHIMATANI et al.
cedure was contraindicated. We gave therapeutic
priority to the squamous cell carcinoma. Fortu-
nately adjuvant chemotherapies were effective for
the lymphoma also. Nevertheless strict follow-up is
essential. Endobronchial echogram after therapy
could not exclude the possibility of residual lym-
phoma just beneath the bronchial mucosa (Fig. 6).
As stated above, we report a case of minute lym-
phoma completely visible via a bronchofiberscope,
accompanied by peripheral lung cancer. This case
might be an extremely rare triple primary disease.
FIGURE 6 Endobronchial echogram after two courses of
chemotherapies showing a hypoechoic layer just beneath the
mucosa (arrow).
The prognosis of curatively resected primary
pulmonary B-cell lymphomas is satisfactory. On
the other hand, the prognosis of advanced lung
cancer is much worse and surgical treatment is the
first option for both neoplasms. Thus, bilateral
thoracotomy might be the best treatment from the
point of view of curability. However, because of
age, PS and pulmonary function, a bilateral pro-
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